Market News & Trends
LGM Pharma Expands Analytical Testing Portfolio With Sannova Analytical Acquisition
LGM Pharma has acquired Sannova Analytical, adding specialized GLP bioanalytical testing and impurity analysis capabilities to its U.S. laboratory services business.
Recipharm Adds Sterile Semi-Solid Manufacturing Capacity at Portuguese Site
Recipharm has commissioned a new sterile cream and ointment production line at its Odivelas, Portugal facility, adding 8–15 million units of annual capacity for pharmaceutical companies seeking sterile semi-solid manufacturing.
HUTCHMED Finalizes GSK Deal for Experimental Targeted Cancer Therapy
HUTCHMED has finalized its licensing agreement with GSK for HMPL-A830, an investigational antibody-targeted cancer therapy, with $110 million upfront and up to $1.185 billion in potential milestones.
Roche and Hansoh Expand Oncology Partnership With ADC Deal Worth Over $15B in Potential Milestones
Hansoh Pharmaceutical and Roche have signed an expanded ADC collaboration and licensing agreement covering a portfolio of antibody-drug conjugates, with $400 million upfront and more than $15 billion in potential milestones.
Cosette Secures First NDA Approval With New EVOXAC Oral Formulation
Cosette Pharmaceuticals has received FDA approval for EVOXAC oral solution for dry mouth symptoms in Sjögren’s disease — the company’s first NDA approval from its own product development.
Systech Introduces Integrated Systems to Streamline Pharmaceutical Packaging and Track-and-Trace Operations
Systech has introduced two integrated packaging systems, the ST15S and ST16P, designed to help pharmaceutical manufacturers automate packaging tasks and meet serialization and traceability requirements.
Eppendorf Brings Research Resources to Munich's Emerging Biotech Companies
Eppendorf has extended its collaboration with BioLabs as a Gold Sponsor at BioLabs | TUM in Munich, providing resident life sciences startups with laboratory equipment, software, maintenance, training, and networking opportunities.
Alentra Brand Launch Reflects Currier's Expansion Into Full-Service CDMO Services
Currier has adopted a new name, Alentra, as the company expands its role in contract development and manufacturing across the healthcare and life sciences industries.…
Kindeva Secures $226M Defense Contract for Nerve Agent Antidote Autoinjectors
Kindeva’s global health security division, Meridian Medical Technologies, LLC, has been awarded a contract valued at up to $226 million by the Defense Logistics Agency…
Takara Bio, SPT Labtech Team Up to Automate NGS Library Preparation
Takara Bio USA, Inc. and SPT Labtech have partnered to make next-generation sequencing (NGS) library preparation more accessible to laboratories seeking to scale throughput and…
Revvity Unveils AI-Powered Workflow Platform to Streamline Drug Development and Manufacturing
Revvity has introduced a new software solution designed to coordinate scientific workflows across research, development, and manufacturing, with the goal of reducing operational disconnects that…
ScionxBio, Sanofi Team Up on Long-Acting mRNA Therapies
ScionxBio has entered into a worldwide strategic collaboration and licensing agreement with Sanofi to develop longer-acting versions of selected mRNA therapeutics, combining the French pharmaceutical…
MVIC, Upperton Partner to Streamline Inhaled and Nasal Drug Development
MVIC (Medicon Valley Inhalation Consortium) and Upperton Pharma Solutions have formed a strategic collaboration aimed at simplifying the path from early drug development to clinical…
Vetter's V-OVS® next Syringe Closure Wins Red Dot Design Concept Award
CDMO Vetter has received a Red Dot Award in the Design Concept category for V-OVS® next, its next-generation syringe closure system designed to improve handling,…
FDA Launches Initiative to Rethink Rare Disease Drug Development Framework
The U.S. Food and Drug Administration (FDA) is launching a new initiative aimed at addressing longstanding challenges in rare disease drug development, including the difficulty…
Senopsys Marks 20 Years of Sensory Science in Pharmaceutical Formulation Development
As pharmaceutical developers place greater emphasis on patient-centric drug design, Senopsys is marking 20 years of helping biopharmaceutical companies address one of formulation development’s practical…
Biomapas Acquires Pinnaxis to Expand Drug Safety Technology Capabilities
Biomapas has acquired Pinnaxis, a pharmacovigilance technology and consulting company based in Noida, India, in a move aimed at expanding its drug safety technology capabilities,…
Thermo Fisher Collaboration Identifies More Than 2,500 New Genetic-Protein Associations
Thermo Fisher Scientific, Precision Health Research, Singapore (PRECISE) and Nanyang Technological University Singapore (NTU Singapore) have identified more than 2,500 previously unreported genetic-protein associations through…
Lonza Extends Accelerated DNA-to-IND Pathway to Complex Biologics
Lonza is expanding its accelerated DNA-to-Investigational New Drug (IND) development offering beyond monoclonal antibodies (mAbs), adding support for more complex biologic formats as drug developers…
Lonza Adds Qurient's CDK7 Inhibitors to Dual-Payload ADC Technology Portfolio
Lonza is expanding its antibody-drug conjugate (ADC) technology portfolio through an exclusive licensing agreement with South Korean biopharmaceutical company Qurient, gaining access to Qurient's cyclin-dependent…
